NDC 70010-199 – Guaifenesin
Guaifenesin 600 mg/1 · Tablet, Extended Release · Oral
Product NDC70010-199
Product details
- Brand name
- Guaifenesin
- Generic name
- Guaifenesin
- Labeler
- GRANULES PHARMACEUTICALS INC.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA213420
- Marketed since
- August 19, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant
Active ingredients
- Guaifenesin 600 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70010-199-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-199-05) | Aug 19, 2022 |
Other Guaifenesin products
- 80513-413 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Advanced Rx LLC
- 46122-750 Guaifenesin 600 mg/1 · Tablet, Extended Release · AMERISOURCE BERGEN
- 65162-036 Guaifenesin 600 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 65162-037 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 58602-865 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-864 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-811 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-853 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-810 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-857 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 21130-179 Guaifenesin 600 mg/1 · Tablet, Extended Release · Better Living Brands LLC
- 68001-561 Guaifenesin 600 mg/1 · Tablet, Extended Release · BluePoint Laboratories